SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-21-055069
Filing Date
2021-10-28
Accepted
2021-10-28 15:07:39
Documents
6
Period of Report
2021-12-17

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT def14a1021_inmed.htm DEF 14A 1429054
2 GRAPHIC tinmed_logo.jpg GRAPHIC 114229
3 GRAPHIC tproxy001.jpg GRAPHIC 1433624
4 GRAPHIC tproxy002.jpg GRAPHIC 1376080
5 GRAPHIC tproxy003.jpg GRAPHIC 1684974
6 GRAPHIC tproxy004.jpg GRAPHIC 1385692
  Complete submission text file 0001213900-21-055069.txt   9688344
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-39685 | Film No.: 211357521
SIC: 2834 Pharmaceutical Preparations